Terms: = Ovarian cancer AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2
3 results:
1. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
[TBL] [Abstract] [Full Text] [Related]
2. The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize ovarian Carcinoma Cells to ABT-737.
Pétigny-Lechartier C; Duboc C; Jebahi A; Louis MH; Abeilard E; Denoyelle C; Gauduchon P; Poulain L; Villedieu M
Mol Cancer Ther; 2017 Jan; 16(1):102-115. PubMed ID: 27980105
[TBL] [Abstract] [Full Text] [Related]
3. Immunophenotypic features of immaturity of neural elements in ovarian teratoma.
Takayama Y; Matsumura N; Nobusawa S; Ikota H; Minegishi T; Yokoo H
Virchows Arch; 2016 Mar; 468(3):337-43. PubMed ID: 26638157
[TBL] [Abstract] [Full Text] [Related]
